HomeSLRX • NASDAQ
add
Salarius Pharmaceuticals Inc
Previous close
$0.83
Day range
$0.82 - $0.86
Year range
$0.46 - $7.20
Market cap
1.77M USD
Avg Volume
178.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.72M | -2.99% |
Net income | -1.71M | 0.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.72M | 2.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.80M | -58.88% |
Total assets | 2.34M | -52.10% |
Total liabilities | 2.28M | 84.55% |
Total equity | 61.87K | — |
Shares outstanding | 2.13M | — |
Price to book | 27.72 | — |
Return on assets | -160.26% | — |
Return on capital | -450.47% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.71M | 0.34% |
Cash from operations | -1.18M | 12.72% |
Cash from investing | — | — |
Cash from financing | 545.57K | 415.81% |
Net change in cash | -636.15K | 58.33% |
Free cash flow | -150.87K | 80.10% |
About
Founded
2014
Headquarters
Website
Employees
2
